Intestinal Immunomodulatory Cells (T Lymphocytes): A Bridge between Gut Microbiota and Diabetes
- PMID: 29713241
- PMCID: PMC5866888
- DOI: 10.1155/2018/9830939
Intestinal Immunomodulatory Cells (T Lymphocytes): A Bridge between Gut Microbiota and Diabetes
Abstract
Diabetes mellitus (DM) is one of the most familiar chronic diseases threatening human health. Recent studies have shown that the development of diabetes is closely related to an imbalance of the gut microbiota. Accordingly, there is increasing interest in how changes in the gut microbiota affect diabetes and its underlying mechanisms. Immunomodulatory cells play important roles in maintaining the normal functioning of the human immune system and in maintaining homeostasis. Intestinal immunomodulatory cells (IICs) are located in the intestinal mucosa and are regarded as an intermediary by which the gut microbiota affects physiological and pathological properties. Diabetes can be regulated by IICs, which act as a bridge linking the gut microbiota and DM. Understanding this bridge role of IICs may clarify the mechanisms by which the gut microbiota contributes to DM. Based on recent research, we summarize this process, thereby providing a basis for further studies of diabetes and other similar immune-related diseases.
Figures

Similar articles
-
[Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].Orv Hetil. 2016 Jan 3;157(1):13-22. doi: 10.1556/650.2015.30296. Orv Hetil. 2016. PMID: 26708682 Review. Hungarian.
-
Role of the gut microbiota in type 2 diabetes and related diseases.Metabolism. 2021 Apr;117:154712. doi: 10.1016/j.metabol.2021.154712. Epub 2021 Jan 23. Metabolism. 2021. PMID: 33497712 Review.
-
Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.BMC Immunol. 2017 Jan 6;18(1):2. doi: 10.1186/s12865-016-0187-3. BMC Immunol. 2017. PMID: 28061847 Free PMC article. Review.
-
Interaction between the gut microbiome and mucosal immune system.Mil Med Res. 2017 Apr 27;4:14. doi: 10.1186/s40779-017-0122-9. eCollection 2017. Mil Med Res. 2017. PMID: 28465831 Free PMC article. Review.
-
[Alteration of intestinal permeability: the missing link between gut microbiota modifications and inflammation in obesity?].Med Sci (Paris). 2016 May;32(5):461-9. doi: 10.1051/medsci/20163205012. Epub 2016 May 25. Med Sci (Paris). 2016. PMID: 27225918 Review. French.
Cited by
-
Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis.World J Gastroenterol. 2023 Feb 14;29(6):967-996. doi: 10.3748/wjg.v29.i6.967. World J Gastroenterol. 2023. PMID: 36844143 Free PMC article. Review.
-
Modulating the gut microbiota and inflammation is involved in the effect of diosgenin against diabetic nephropathy in rat.Front Pharmacol. 2025 May 19;16:1555849. doi: 10.3389/fphar.2025.1555849. eCollection 2025. Front Pharmacol. 2025. PMID: 40458807 Free PMC article.
-
Changes in Intestinal Microbiota Are Associated with Islet Function in a Mouse Model of Dietary Vitamin A Deficiency.J Diabetes Res. 2020 Jan 21;2020:2354108. doi: 10.1155/2020/2354108. eCollection 2020. J Diabetes Res. 2020. PMID: 32064275 Free PMC article.
-
Immunoregulatory Intestinal Microbiota and COVID-19 in Patients with Type Two Diabetes: A Double-Edged Sword.Viruses. 2022 Feb 25;14(3):477. doi: 10.3390/v14030477. Viruses. 2022. PMID: 35336884 Free PMC article. Review.
-
Clinical Implications of the Associations Between Intestinal Microbiome and Colorectal Cancer Progression.Cancer Manag Res. 2020 Jun 9;12:4117-4128. doi: 10.2147/CMAR.S240108. eCollection 2020. Cancer Manag Res. 2020. PMID: 32606919 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical